Moteur de recherche d’entreprises européennes
Financement de l’UE (2 567 165 €) : La prochaine étape vers l’élimination de la carence en iode et des troubles évitables liés à l’iode en Europe Hor29/11/2022 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
La prochaine étape vers l’élimination de la carence en iode et des troubles évitables liés à l’iode en Europe
The iodine status is a primary determinant of thyroid disorders, which are a major cause of morbidity, particularly in women. In addition, even mild-to-moderate iodine deficiency during pregnancy is related to neurocognitive impairment in the offspring. Iodine deficiency imposes tremendous costs on the health-care systems of affected regions, but can easily be prevented by iodine fortification programmes. In many countries, iodine deficiency receives surprisingly little publicity. The initial EUthyroid consortium evaluated European prevention programmes against iodine deficiency and uncovered major limitations including the low awareness on the importance of iodine for healthy living. EUthyroid2 will now fill important gaps in the prevention of iodine deficiency in Europe and beyond. The main objective of EUthyroid2 is to improve the low awareness with respect to iodine deficiency-related risks in adolescents and young women. The major aim is to find best practice models for accessing and informing them to increase their awareness and to improve their iodine status in order to lay the foundation for their own thyroid and general health and that of their offspring. Implementation studies and community-based randomised-controlled trials will be conducted with the objective of increasing iodine-related awareness in adolescents and young women up to age of 24 before pregnancy. The interventions are multimodal and performed in the two settings educational system and ambulatory care in eight study regions. As public health project EUthyroid2 is not only science, but will also serve our societies. Therefore, dissemination of findings to various sectors of our countries and the EU will be of utmost importance. By finding best practice models to raise the awareness on the importance of iodine for a healthy life of their own and their offspring in young people, EUthyroid2 will lay the foundation for a cost-effective way to eradicate iodine deficiency-related disorders.
| Iodine Global Network | ? |
| Bangladesh University OF Health Sciences Trust | 36 581 € |
| Charite - Universitaetsmedizin Berlin | 132 512 € |
| Danmarks Tekniske Universitet | 188 460 € |
| Havforskningsinstituttet | 384 688 € |
| Heinrich-Heine-Universitaet Duesseldorf | 149 200 € |
| Islamia College Peshawar | 36 721 € |
| Technologiko Panepistimio Kyprou | 132 313 € |
| Thyroid Federation International | 200 250 € |
| Universitatsmedizin Greifswald KöR | 928 190 € |
| Univerzitetni Klinicni Center Ljubljana | 236 313 € |
| Uniwersytet Jagiellonski | 130 688 € |
| Vastra Gotalandsregionen | 11 250,00 € |
https://cordis.europa.eu/project/id/101095643
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Iodine Global Network, Ottawa, Canada.
